Wall Street Analysts Believe AXT (AXTI) Could Rally 25.27%: Here's is How to Trade
AXT closed at $73.12 after gaining 38.2% in four weeks. Analysts’ mean target of $91.6 implies 25.3% upside, while higher earnings estimates and a Zacks Rank #1 support the near-term case.
AXT Inc. (AXTI) closed its latest session at $73.12, up 38.2% over the past four weeks. Wall Street’s average short-term price target is $91.6, indicating 25.3% potential upside. The estimate combines five targets and has a $24.86 standard deviation. Forecasts vary widely. The lowest target is $55.00, implying a 24.8% decline from the current price, while the most optimistic analyst expects AXTI to reach $125.00, representing a 71% gain. The standard deviation measures dispersion: a smaller figure would indicate greater agreement, while the current level signals substantial uncertainty. Price, Consensus and EPS Surprise A consensus price target can help frame an investment thesis, but it should not determine an investment decision. Research from several universities indicates that analyst targets frequently mislead investors and rarely predict where a stock will trade, even when estimates are closely aligned. Analysts may understand company fundamentals and economic or industry sensitivities, yet business relationships can encourage firms to promote companies they serve or hope to associate with, contributing to overly optimistic targets. Tightly clustered targets can still provide a starting point for researching the fundamental forces affecting a stock. For AXTI, the improving earnings outlook may be more significant. Analysts have agreed in revising EPS estimates higher, and empirical research shows a strong correlation between earnings-estimate revision trends and near-term share-price movements. The Zacks Consensus Estimate for the current year has risen 322.8% over the past month. Three estimates increased, while none moved lower. AXTI also carries a Zacks Rank #1 (Strong Buy), placing it among the top 5% of more than 4,000 stocks ranked using four earnings-estimate factors. Zacks’ externally audited track record makes the rank a potentially more useful near-term signal than the price target alone. The target may not reliably measure AXTI’s eventual gain, but its implied direction, supported by earnings revisions, could guide further research. Zacks also offers “7 Best Stocks for the Next 30 Days” and a free AXTI analysis report through zacks.com.



